Human papillomavirus vaccine: 2-1-1 helplines and minority parent decision-making

Lara S Savas, Maria E Fernández, David Jobe, Chakema C Carmack, Lara S Savas, Maria E Fernández, David Jobe, Chakema C Carmack

Abstract

Background: Research is needed to understand parental factors influencing human papillomavirus (HPV) vaccination, particularly in groups with a higher burden of cervical cancer.

Purpose: To determine correlates of HPV vaccination among a sample of low-income parents of age-eligible daughters (aged 9-17 years) who called the 2-1-1 Helpline. Secondary analyses describe potential differences in HPV vaccination correlates by Hispanic and black parent groups, in particular.

Methods: This 2009 cross-sectional feasibility survey of cancer prevention needs was conducted in Houston at the 2-1-1 Texas/United Way Helpline. In 2012, to examine the association between parental psychosocial, cognitive, and decisional factors and HPV vaccination uptake (one or two doses), bivariate and multivariable logistic regression analyses were conducted for minority parents and for Hispanic and black parent groups, separately.

Results: Lower rates of HPV vaccination uptake were reported among minority daughters of 2-1-1 callers (29% overall) compared with national and Texas rates. In final adjusted analysis, factors positively associated with HPV vaccination uptake included being offered the vaccination by a doctor or nurse, belief that the vaccine would prevent cervical cancer, and Hispanic ethnicity. Secondary analyses detected differences in factors associated with vaccination in Hispanic and black groups.

Conclusions: Findings indicate low levels of vaccination among 2-1-1 callers. Increased understanding of determinants of HPV vaccination in low-income minority groups can guide interventions to increase coverage. Because 2-1-1 informational and referral services networks reach populations considered medically underserved, 2-1-1 can serve as a community hub for informing development of and implementing approaches aimed at hard-to-reach groups.

Copyright © 2012 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

References

    1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012. [Accessed February 2, 2012]. Available at: URL: .
    1. American Cancer Society. [Accessed March, 25, 2011];Cancer Facts & Figures for African Americans 2011–2012. 2011 :1–28. Available at: URL: .
    1. American Cancer Society. [Accessed February 18, 2010];Cancer Facts and Figures for Hispanics/Latinos 2009–20011. 2009 Available at: URL: .
    1. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004 Nov 13;364(9447):1757–1765.
    1. Koutsky LA, Ault KA, Wheeler CM. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002 Nov 21;347(21):1645–1651.
    1. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med. 2007 Aug;45(2–3):107–114.
    1. Slomovitz BM, Sun CC, Frumovitz M, et al. Are women ready for the HPV vaccine? Gynecol Oncol. 2006 Oct;103(1):151–154.
    1. Fernandez ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2010 Apr 21;31:235–252.
    1. Allen JD, Othus MK, Shelton RC, et al. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2187–2198.
    1. Bastani R, Glenn BA, Tsui J, et al. Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011 May 20;
    1. Lechuga J, Swain GR, Weinhardt LS. The cross-cultural variation of predictors of human papillomavirus vaccination intentions. J Womens Health (Larchmt) 2011 Feb;20(2):225–230.
    1. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009 Aug;69(3):475–480.
    1. The United Way of Greater Houston. 2010 United Way Community Assessment. 2012;28 .
    1. The United Way of Greater Houston. The United Way of Greater Houston Annual Report 2009: Reaching Out. 2009;24 .
    1. Willis GB. Cognitive Interviewing: A Tool for Improving Questionnaire Design. Thousand Oaks, CA: Sage; 2005.
    1. Fishbein M. A reasoned action approach to health promotion. Med Decis Making. 2008 Nov;28(6):834–844.
    1. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006 May;117(5):1486–1493.
    1. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009 Nov;45(5):528–531.
    1. Agency for Healthcare Research and Quality. Health Care for Minority Women: Recent Findings. 2010 Pub. No. 11P005. .

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren